TETRAKRIS

This brand name is authorized in Nigeria.

Active ingredients

The drug TETRAKRIS contains one active pharmaceutical ingredient (API):

1	Tetracycline UNII P6R62377KV - TETRACYCLINE HYDROCHLORIDE
	Tetracyclines are taken up into sensitive bacterial cells by an active transport process. Once within the cell they bind reversibly to the 30S subunit of the ribosome, preventing the binding of aminoacyl transfer RNA and inhibiting protein synthesis and hence cell growth.
	Read more about Tetracycline

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A11-100425	Capsule	Tetrakris+++ CAP 250 mg 10 x 10's (in Alu-PVC blisters)	Hard capsule Hard gelatin capsule, maroon cap and yellow body 6/20/2024 12:19:44 TETRAKRIS Tetracycline HCL 250mg A11-100425 Capsule Oral Tetracycline HCL 250mg 10x10 capsules POM Krishat Pharma Industries Limited KM 15, Lagos Ibadan Expressway, Ibadan, Oyo State, Nigeria Krishat Pharma Industries Limited KM 15, Lagos Ibadan Expressway, Opp. Oriental Foods, Ibadan, Oyo State, Nigeria Nigeria 25/08/2022 24/08/2027 Yes J01AA07	25/08/2022

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01AA07	Tetracycline	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01A Tetracyclines → J01AA Tetracyclines
Discover more medicines within J01AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A11-100425